Delivery Order SPE2DB24D9238-SPE2DB25FDQNF

Award Date 2/20/25
Potential Completion Date 3/13/25
Potential Value $1.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $7,900.20 firm fixed-price delivery order is for the supply of KYLEENA 19.5 MG SYSTEMS, a medical product, with a completion date of June 30, 2022. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the...
This federal contract award, valued at $14,002.56, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order to supply the KYLEENA 19.5 MG SYSTEMS product. DMS Pharmaceutical Group Inc. holds a large indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which runs through December 31, 2025. This single-award vehicle, under the...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $1,814.82, is for the delivery of the pharmaceutical product KYLEENA 19.5 MG SYSTEMS. This delivery order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued up to $499,999,999, which runs through December 31, 2025. The IDC allows...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $1,209.88 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of KYLEENA 19.5 MG SYSTEMS, a pharmaceutical product, with a period of performance through November 27, 2024. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a wide range of branded and generic prescription drugs,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,385.80 firm fixed-price delivery order is for the supply of KYLEENA 19.5 MG SYSTEMS, a specialized pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. This IDC...
This federal contract award is a delivery order valued at $2,919.35 issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award is for the supply of a pharmaceutical product called "KYLEENA 19.5 MG SYSTEMS" and has a performance period through October 4, 2024. DMS Pharmaceutical Group holds a large indefinite delivery contract (IDC) with the DLA under the SPE2DB program,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,209.88, is a firm fixed-price delivery order for the supply of 4565110641 KYLEENA 19.5 MG SYSTEMS, a pharmaceutical product. The contract has an ultimate completion date of July 24, 2024 and was awarded on July 2, 2024. DMS Pharmaceutical Group Inc. holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler located in Park Ridge, Illinois. The $3,009.65 firm fixed-price delivery order is for the procurement of KYLEENA 19.5 MG SYSTEMS, a specialized pharmaceutical product. This award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program, which...
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $2,347.24 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of KYLEENA 19.5 MG SYSTEMS, a pharmaceutical product, with a period of performance through December 16, 2024. This award is part of a larger $499,999,999 Indefinite Delivery Contract held by DMS Pharmaceutical Group Inc. with the DLA under...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $3,611.58 firm fixed-price delivery order is for the supply of the KYLEENA 19.5 MG SYSTEMS pharmaceutical product. The award is not designated as a set-aside contract. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency...
  • SPE2DB24D9238
    Indefinite Delivery Contract
  • SPE2DB24D9238-SPE2DB25FDQNF
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,859.07 firm fixed-price delivery order is for the supply of KYLEENA 19.5 MG SYSTEMS, a specialized pharmaceutical product. The contract has an ultimate completion date of March 13, 2025.

DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. This specific delivery order is not associated with any set-aside designation, allowing DMS Pharmaceutical Group to leverage its status as a woman-owned small business to secure direct federal awards across multiple product categories and medical domains.

Generated 5/22/25, 8:21 PM